CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells
Yanrong Lv1, Shanshan Song2, Kai Zhang1
1Department of Breast Surgery, QiLu Hospital of Shandong University, Jinan, Shandong, China.
Abstract:
A number of studies have shown that apoptosis resistance can be observed in multiple human tumors; however the detailed mechanism remains unclear. In the present study, we demonstrated that the abnormal overexpression of the C terminus of Hsc70-interacting protein (CHIP) induced apoptosis resistance by regulating the AKT/FoxO/Bim signaling pathway in the breast cancer cell MCF7 and the human non-tumorigenic cell MCF10A. We found that CHIP overexpression in MCF7 and MCF10A cells activated AKT and inhibited the Forkhead box O (FoxO) transcription factors FoxO1, FoxO3, and FoxO4, thereby inhibiting transcription of the target genes bim and pten. Inhibition of PI3K by a chemical reagent revealed that these events may be critical for CHIP-induced apoptosis resistance. We also determined that inhibition of FoxO3 by CHIP led to the decrease in PTEN and further activated the AKT survival pathway. We corroborated our findings in breast cancer tissues. In general, the CHIP-modulated AKT/FoxO/Bim signaling pathway was shown to induce apoptosis resistance by decreasing the protein level of the tumor suppressor PTEN in both transcriptional and post-translational regulations.
Insights
Overexpression of C-terminus of Hsc70-interacting protein (CHIP) promotes cancer cell survival by disrupting the AKT/FoxO/Bim pathway, leading to apoptosis resistance. This mechanism involves regulating PTEN levels in breast cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Apoptosis resistance is a hallmark of many human cancers, yet its underlying mechanisms are not fully understood.
- The C-terminus of Hsc70-interacting protein (CHIP) has been implicated in various cellular processes, but its role in apoptosis resistance requires further elucidation.
Purpose of the Study:
- To investigate the role of CHIP overexpression in inducing apoptosis resistance.
- To elucidate the molecular mechanisms by which CHIP regulates apoptosis resistance, focusing on the AKT/FoxO/Bim signaling pathway.
Main Methods:
- Utilized breast cancer (MCF7) and non-tumorigenic (MCF10A) cell lines to study CHIP overexpression.
- Investigated the effects of CHIP on AKT, Forkhead box O (FoxO) transcription factors (FoxO1, FoxO3, FoxO4), Bim, and PTEN.
- Employed PI3K inhibition to assess the critical signaling events in CHIP-induced apoptosis resistance.
- Examined CHIP's role in regulating PTEN at both transcriptional and post-translational levels.
- Corroborated findings in human breast cancer tissues.
Main Results:
- CHIP overexpression activated AKT and inhibited FoxO transcription factors (FoxO1, FoxO3, FoxO4) in MCF7 and MCF10A cells.
- CHIP overexpression led to the inhibition of Bim and PTEN transcription.
- Inhibition of PI3K confirmed its critical role in CHIP-induced apoptosis resistance.
- CHIP-mediated inhibition of FoxO3 resulted in decreased PTEN levels and further activation of the AKT survival pathway.
- Findings were validated in clinical breast cancer samples.
Conclusions:
- CHIP overexpression induces apoptosis resistance in breast cancer cells by modulating the AKT/FoxO/Bim signaling pathway.
- CHIP regulates PTEN protein levels through both transcriptional and post-translational mechanisms, contributing to apoptosis resistance.
- The CHIP-AKT/FoxO/Bim axis represents a potential therapeutic target for overcoming apoptosis resistance in cancer.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
TGF - β Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


